Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

Caring for Patients With Complex Brain Tumors and Clinical Implicati…

Yale Cancer Center

J. Moliterno, E. Winer

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe

BRAF in the MAPK Pathway for Pediatric Low-Grade Glioma: Current Tes…

Avani Mangoli

LITT for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk …

Hassan Fadel

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Key Practice-Changing Studies in Neuro-Oncology: Rapid Insights Acro…

Yale Cancer Center

N. Blondin

Endoscopic Pituitary Surgery: State-of-the-Art & The Cavernous Sinus

San Francisco Neurological Society

J. Fernandez-Miranda

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clin…

AACR 2023 Conference Coverage

M. Gouda

Biomarkers in Diffuse Midline Glioma

University of Colorado Department of Medicine

A. Green

Pediatric Low Grade Glioma: Radiation in the Targeted Therapy Era

Rene McNall-Knapp

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Value of NGS in Solid Tumors

Michelle Shiller

Overview and Updates in Brain Tumors

Henry Friedman

Penn Medicine Updates in Oncology 2023: Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley

ASCO 2022: Dabrafenib + Trametinib Significantly Increases Overall R…

ecancer

E. Bouffet

Awake Surgery With Cognitive Mapping for Low-Grade Gliomas: a Connec…

Hugues Duffau

Penn Medicine Updates on Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley